In accordance with the principles of the nomination committee of Xbrane Biopharma AB, adopted at the Annual General Meeting on 24 May 2018, the Nomination Committee shall consist of up to four members appointed by the three shareholders as of September 30, 2018. The fourth member shall be the chairman of the board. Based on the above, the Nomination Committee for the Annual General Meeting in 2019 has been set up to consist of the following persons, which together represent approximately 17.6% of the number of shares and votes in the company as of September 30, 2018: Ashkan Pouya appointed by Serendipity Group AB (Chairman of the Nomination Committee); Paolo Sarmientos appointed by Paolo Sarmientos; and Anders Tullgren, Chairman of Xbrane. The Chairman of the Board has contacted the eight shareholders in accordance with the principles of the Nomination Committee, whereby two shareholders expressed their willingness to appoint members of the Nomination Committee. Accordingly, the Nomination Committee consists of at least three members in accordance with the principles adopted by the Annual General Meeting.